Profile data is unavailable for this security.
About the company
Notable Labs Ltd, formerly Vascular Biogenics Ltd, is an Israel-based clinical-stage biopharmaceutical company committed to developing next-generation, targeted medicines for difficult-to-treat medical conditions. The Company has created a pipeline of therapeutics that address cancer and immune-inflammatory diseases with the goal of significantly improving patient outcomes and overcoming the limitations of approved treatments. The Company's product candidates are built off of two platform technologies: Vascular Targeting System (VTS), a gene-based technology targeting newly formed blood vessels, and Monocyte Targeting Technology (MTT), an antibody-based technology able to specifically inhibit monocyte migration for immune-inflammatory applications.
- Revenue in USD (TTM)313.00k
- Net income in USD-16.74m
- Incorporated2000
- Employees16.00
- LocationNotable Labs Ltd320 Hatch DriveFOSTER CITY 94404United StatesUSA
- Phone+1 (415) 851-2410
- Fax+972 8993-5001
- Websitehttps://notablelabs.com/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Oragenics Inc | 7.47k | -19.52m | 4.16m | 5.00 | -- | -- | -- | 556.41 | -6.99 | -6.99 | 0.0023 | 0.2377 | 0.0013 | -- | -- | 1,494.00 | -349.31 | -97.60 | -451.26 | -106.24 | -- | -- | -261,261.60 | -36,169.75 | -- | -- | 0.00 | -- | -71.37 | -- | -44.56 | -- | 51.64 | -- |
Peak Bio Inc | 354.02k | -4.63m | 4.16m | -- | -- | -- | -- | 11.76 | -0.2066 | -0.2066 | 0.0135 | -0.9769 | 0.2192 | -- | -- | -- | -286.54 | -- | -- | -- | -- | -- | -1,307.11 | -- | -- | -4.85 | -- | -- | -39.46 | -- | 2.01 | -- | -- | -- |
Creative Medical Technology Holdings Inc | 17.00k | -5.73m | 4.17m | 4.00 | -- | 0.5484 | -- | 245.59 | -4.07 | -4.07 | 0.012 | 5.69 | 0.0015 | 1.00 | -- | 4,250.00 | -51.83 | -110.00 | -53.71 | -- | 60.00 | 65.82 | -33,716.41 | -7,961.14 | 20.20 | -- | 0.00 | -- | -89.84 | -40.86 | 47.88 | -- | -- | -- |
Azitra Inc | 408.20k | -9.96m | 4.19m | 10.00 | -- | 0.3059 | -- | 10.27 | -12.12 | -12.12 | 0.1151 | 1.80 | 0.0595 | -- | 1.83 | 40,820.00 | -145.30 | -- | -194.72 | -- | -- | -- | -2,440.46 | -- | -- | -- | 0.0191 | -- | 141.55 | -- | 6.02 | -- | -- | -- |
Lixte Biotechnology Holdings Inc | 0.00 | -4.03m | 4.23m | 3.00 | -- | -- | -- | -- | -1.83 | -1.83 | 0.00 | 0.9986 | 0.00 | -- | -- | 0.00 | -139.98 | -104.18 | -163.33 | -111.05 | -- | -- | -- | -- | -- | -563.88 | 0.00 | -- | -- | -- | 19.41 | -- | -- | -- |
Enveric Biosciences Inc | 0.00 | -10.59m | 4.24m | 7.00 | -- | 0.6924 | -- | -- | -3.67 | -3.67 | 0.00 | 0.6862 | 0.00 | -- | -- | 0.00 | -133.67 | -104.94 | -206.10 | -156.88 | -- | -- | -- | -243.54 | -- | -- | 0.00 | -- | -- | -- | 7.14 | -- | -- | -- |
Galera Therapeutics Inc | 0.00 | -29.11m | 4.30m | 7.00 | -- | -- | -- | -- | -0.5892 | -0.5892 | 0.00 | -2.54 | 0.00 | -- | -- | 0.00 | -90.03 | -83.69 | -119.01 | -97.54 | -- | -- | -- | -- | -- | -14.34 | 11.60 | -- | -- | -- | 5.05 | -- | -29.84 | -- |
Notable Labs Ltd | 313.00k | -16.74m | 4.34m | 16.00 | -- | 0.6037 | -- | 13.86 | -2.47 | -2.47 | 0.046 | 0.7439 | 0.0176 | -- | -- | 19,562.50 | -93.89 | -52.02 | -120.26 | -62.09 | 37.70 | 60.19 | -5,346.97 | -3,636.93 | -- | -- | 0.0405 | -- | -52.89 | -11.93 | 65.13 | -- | -50.69 | -- |
Synaptogenix Inc | 0.00 | -3.45m | 4.39m | 5.00 | -- | 0.2229 | -- | -- | -3.89 | -3.89 | 0.00 | 14.99 | 0.00 | -- | -- | 0.00 | -5.54 | -40.33 | -6.89 | -43.36 | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | -142.17 | -- | -3.21 | -- |
Alaunos Therapeutics Inc | 7.00k | -19.13m | 4.42m | 1.00 | -- | 1.17 | -- | 631.35 | -11.95 | -11.95 | 0.0044 | 2.36 | 0.0004 | -- | 1.75 | 7,000.00 | -117.34 | -74.83 | -143.58 | -89.57 | -- | -- | -273,271.40 | -10,508.06 | -- | -- | 0.00 | -- | -99.83 | -49.08 | 6.86 | -- | -15.56 | -- |
Palisade Bio Inc | 0.00 | -14.17m | 4.45m | 9.00 | -- | 0.3653 | -- | -- | -20.07 | -20.07 | 0.00 | 10.30 | 0.00 | -- | -- | 0.00 | -90.97 | -132.36 | -109.07 | -165.45 | -- | -- | -- | -27,892.32 | -- | -972.73 | 0.0339 | -- | -- | -0.7814 | 13.74 | -- | 18.53 | -- |
Oncternal Therapeutics Inc | 1.85m | -35.97m | 4.53m | 27.00 | -- | 0.2875 | -- | 2.45 | -12.19 | -12.19 | 0.6254 | 5.32 | 0.0495 | -- | -- | 68,370.37 | -96.40 | -49.40 | -116.52 | -54.51 | -- | -- | -1,948.70 | -1,342.98 | -- | -- | 0.00 | -- | -47.32 | -- | 10.62 | -- | -- | -- |
Qualigen Therapeutics Inc | 0.00 | -9.27m | 4.57m | 4.00 | -- | -- | -- | -- | -1.66 | -1.75 | 0.00 | -0.445 | 0.00 | -- | -- | 0.00 | -134.64 | -- | -- | -- | -- | -- | -- | -- | -- | -9.64 | -- | -- | -- | -- | 10.22 | -- | -- | -- |
CNS Pharmaceuticals Inc | 0.00 | -15.97m | 4.60m | 3.00 | -- | -- | -- | -- | -134.04 | -134.04 | 0.00 | -2.97 | 0.00 | -- | -- | 0.00 | -358.12 | -132.47 | -- | -185.75 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -23.42 | -- | -- | -- |
Holder | Shares | % Held |
---|---|---|
Squarepoint OPS LLCas of 31 Mar 2024 | 63.70k | 0.66% |
Geode Capital Management LLCas of 30 Jun 2024 | 29.62k | 0.31% |
Mariner LLCas of 31 Mar 2024 | 22.00k | 0.23% |
Virtu Americas LLCas of 30 Jun 2024 | 21.95k | 0.23% |
Oppenheimer & Co., Inc. (Wealth Management)as of 30 Jun 2024 | 20.00k | 0.21% |
Morgan Stanley & Co. LLCas of 31 Mar 2024 | 19.30k | 0.20% |
Two Sigma Securities LLCas of 31 Mar 2024 | 14.44k | 0.15% |
XTX Markets LLCas of 31 Mar 2024 | 10.19k | 0.11% |
Wells Fargo Clearing Services LLCas of 31 Mar 2024 | 5.00k | 0.05% |
UBS Securities LLCas of 31 Mar 2024 | 3.93k | 0.04% |